Introduction
Gene therapy holds great promise toward treating genetic disease, and many researchers are moving toward clinical application of this approach. One of the challenges faced is determining how viral integration events cause phenotypic changes in cells that eventually lead to cancer risk or malignant transformation. 1 Many recent studies have begun to address this challenge. 2, 3 These studies, and their resulting publications, have described the abundance and location of vector integration sites in normal and malignant cells using experimental methods such as ligation-mediated PCR (LM-PCR) or linear amplification-mediated PCR (LAM-PCR) in both human and model organisms. 2, 4, 5 Ligation-mediated PCR and linear amplificationmediated PCR seek to identify retroviral vector integration sites by digesting genomic DNA with an appropriate restriction enzyme and by using PCR primers within the long terminal repeats and an adapter fragment to amplify the long terminal repeat-genomic DNA junctions. 6, 7 Investigators may sequence the PCR product directly or through Topo-cloning methods. 8 However, bioinformatic protocols are frequently used to describe genomic sites, and different gene annotations and genome builds are used. Although the integration sites are fixed, these variations in genome builds and gene models can lead to differences in position, resulting in statistical analyses that are difficult to compare.
Here we describe an automated web-based approach for annotating large numbers of viral integration sites. This software, named SeqMap, accepts sequences, removes vector and repeating elements, maps to a genome sequence and then extracts annotations from both the University of California Santa Cruz (UCSC) and Ensembl genome annotations. Information such as nearby genes, their associated Gene Ontology (GO) functions, the distance of the integration site to the gene start sites and the orientation of the integration is tabulated. Reports can be generated on webpages and in Excel.
Construction of this tool was motivated by our need to understand both where and how often genome viral integrations were occurring, and also to understand why certain sample submissions were failing to identify an insertion site from an LM-PCR product. It is often challenging to determine the underlying causes of a failure to identify a site when annotations are being built by hand or from a script. We find that these failures can arise from a variety of sources, including integration into areas of genomic repeating elements (that is, satellite or LINE repeats), sample contamination, too little genomic sequence to map or poor sequence quality. These causes can be readily determined using our tools, and, if addressable, the user is able to override the annotations with their own. The data can then be exported for further analysis if required. Details of the analysis follow.
Database and analysis
SeqMap is constructed using the Python (http:// python.org/) programming language, with MySQL (http://mysql.com/) as a backend database. Bioperl (http://bioperl.org/) is used to render images of genetic structure. UCSC GoldenPath (http://genome.ucsc.edu/) and Ensembl (http://ensembl.org/) annotations, sequences and related tools are all stored locally, ensuring that data annotations are stable over time.
Genome mapping
In using the SeqMap tool, the user inputs the vector sequences (and sequences generated during Topo cloning) so these sequences can be removed prior to searching. The species being analyzed is indicated and the appropriate databases are then selected by SeqMap. Submission of the sequencing data is performed by formatting the sequences in FASTA file format, and giving each sequence a title in the form of SeqID. SampleID. The method will automatically split the title by '.', and all characters on the left of the first '.' will be the unique identifier for that sequence. The characters on the right will be the identification for the sample. Multiple sequences can map to a single sample. Sample IDs can be used later to perform analysis on groups of integration sites. Once the sequences are submitted, the server begins to execute the workflow in Figure 1 .
Upon submission of sequences and related vector construct structures (in FASTA format), SeqMap automatically maps the genomic sequences to the genome using the following steps. First, the local alignment tool Chaos 9 is used to mask each submitted vector sequence out of each input sequence. The submitted vector sequences are iteratively mapped to the input sequences and any resulting alignments are removed. The Censor tool is then used to remove repeats. As many integration sites occur in repeating elements, this process allows SeqMap to identify and display such portions of the sequence for the user. The input sequences are compared with the RepBase database, 10 identifying any repeats present in the sequence, which are then masked out. The resulting masked sequences are mapped to the GoldenPath and Ensembl genome sequences using BLASTlike alignment tool (Blat) 11 for both mouse and human sites, provided there is enough non-repeating content to accomplish the task. A cutoff of at least 95% identity is required for a Blat hit to be considered. All hits that meet this constraint are reported so that the user can identify ambiguous sequences or sequences with multiple mappable positions. It is possible that a sequence containing a nearby repeat is still mappable; however, we allow technicians to override the annotation with an analysis by hand.
Local sequence alignments, with the long terminal repeats at the junctions, are performed using Chaos. Only complete junctions are reported as including integration sites. The orientation of the integration is also found, given as 'A' or 'B', specifying the orientation of the integrated sequence on the reference genome. Nearby genes within 300 kb are identified from both annotation databases using the RefSeq tables and are connected using their Entrez Gene or Mouse Genome Informatics IDs. These IDs are used to determine whether nearby transcripts come from the same or different genes.
This process is able to map very large numbers of sites; submissions can include hundreds of sequences. Analyses can be grouped by a user-specified sample ID or date of submission, and links are provided to the public genome databases. Common integration sites from the retroviral tagged cancer gene database (RTCGD) 12 are highlighted in bold if the samples are from mice. Users are able to create group pages, submit batches of data, return later and view the automatic annotations, and build statistics by submission and user-defined samples. The workflow is not completed until the 'Mapped' flag is set to '1' on the sample list page (Figure 2 ). Once the workflow is completed, the user can click through to each submission and graphically observe the structure of the submitted sequence including regions of poor sequence ('N'), vector, repeating elements and the genomic region. In addition, nearby genes from both the Ensembl and UCSC databases can be observed on a map, and the nearest transcription start sites to the integration site are determined. Finally, reports can be Figure 1 Automated workflow for annotation in SeqMap. First, the user must specify the vector sequence to be removed from the input sequences; this only needs to be done once per LM-PCR protocol. Next, sequences are inputted in FASTA format, one for each submitted sequence. Then, each sequence is mapped to the genome, using the following three-step protocol. First, the Lagan 9 toolkit's local alignment method, Chaos, is used to identify regions of vector in the inputted sequence; regions of vector are replaced with the letter 'N'. Second, Censor 10 , a repeat-masking algorithm, is applied to the vector-removed sequence to remove repeating elements. Finally, the resulting sequence is mapped to the genome build using Blat. Then, nearby RefSeq (http://www.ncbi.nlm.nih.gov/RefSeq/) gene products are identified near the integration site using both the Ensembl and UCSC annotation databases; only genes with Entrez Gene IDs or MGI IDs are considered. Distances are from the specified integration site to the 'txStart' location in UCSC or the 'Start' location in Ensembl. Parameters for each of these tools are published on our online reference guide at http://seqmap.compbio.iupui.edu/. Blat, BLAST-like alignment tool; LM-PCR, ligationmediated PCR; MGI, Mouse Genome Informatics.
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Identification of nearby genes
The summary of the identified integration sites can be viewed directly by clicking on the gene map link, which provides a visualization of the genetic structure around the integration site on both UCSC and Ensembl RefSeq annotations. 13 Characterization of nearby genes and elucidated integration sites and EBI Gene Ontology annotations. We highlight both the UCSC GoldenPath annotations and the Ensembl annotations as both a quality control measure and to enable cross database communication for users of one particular database. Exporting a summary of every submission into Excel is possible by clicking on the export to Excel link on each summary page (Figure 2a ).
Example submission
It is useful to view an example data set submission to understand how this resource can be used. One of our challenges is creating an interface that is not only featurerich and useful, but also easy to use by the bench scientist who may have little or no familiarity with bioinformatics tools. To overcome this, we chose a web-based solution that enables researchers to upload the sequences and vectors of interest and then run the automated analysis on our servers. By completing this workflow, Figure 2 Example of an integration-site submission. At the left is the submission summary (a), and below, each submission is summarized by sequence name (b). At the right is a specific integration-site summary page (c). Each sequence submission is summarized based on whether it is confirmed by a technician, used for analysis, contains a technician comment, whether it is found on the genome and what UCSC and Ensembl have annotated as the closest gene. Genes in the RTCGD 12 are highlighted in bold. A gene structure map is visualized showing any original sequence errors ('N's), the blocks removed by vector removal, any repeating elements, the genomic region mapped to the genome and the proposed integration site. The structure of the inputted sequence is shown in user-configurable colors in both the image map and the sequences. A summary of all status, comments and nearby genes found with links to a complete summary of that region of the genome for each annotation database is also given. For model organisms, human orthologs are provided using the Jackson Laboratory ortholog tables (http://www.informatics.jax.org/). The sequences outputted by each step of the preparation process are displayed. RTCGD, retroviral-tagged cancer gene database. 
username 'demo', password 'demo'. In addition, all integration sites at a particular genomic position can be viewed with a map of the nearby genes ( Figure 3) .
When used, we find that we are able to automatically map sites in a manner that agrees with human annotation, and we are able to interpret experimental results that fail to identify a genomic site.
Analysis of large numbers of genomic sequences is an increasingly important problem in areas outside gene therapy research. SeqMap has been developed to enable similar analyses in such other domains. If a researcher generates a significant amount of sequence data that need to be mapped to a genome, SeqMap will support this. We believe this resource will enable users to accurately compare their results with those of other experiments and publications in a consistent manner. Future additions include analysis of functional annotations and nearby genes using Gene Ontology and the ability to publish public reports based on the results. Together, these tools will represent a significant advance in our ability to analyze insertional mutagenesis data, and we will continue to improve this tool as new experimental methods are determined.
